Skip to main content

Table 1 Overview of discussed graphene antibody-based nanosensors

From: Recent advances in graphene-based biosensor technology with applications in life sciences

Target

Immunosensor design

Detection methods

Antibody

Antibody binding

Detection limit

Refs.

Escherichia coli

Graphene oxide cellulose nanopaper

Photoluminescence

Antihuman IgG Ab

Conjugation process

1.60 ng/mL

[50]

Graphene/PMMA

Electrical

Anti E. coli O157:H7 antibody

–

10 CFU/mL

[38]

Graphene

Electrical

Anti-E. coli antibody

Via PASE linker

10 CFU/mL

[31]

Graphene

Electrical

Anti-E. coli O157:H7 antibodies

Via PASE linker

10–107 cells/mL

[32]

Reduced graphene oxide

Electrical

Generic anti-E. coli antibody

EDC–NHS chemistry

103 CFU/mL

[37]

Salmonella typhimurium

GO–AgNPs nano composite

Cyclic voltammetry

Anti-S. typhimurium

EDC–NHS chemistry

10 CFU/mL

[39]

Zika virus

Graphene

Electrical

Anti-Zika NS1

NHS surface chemistry

0.45 nM

[33]

Dengue virus

Graphene oxide

Electrochemical impedance spectroscopy

4G2 monoclonal antibody

Electrostatic bond

0.12 PFU /mL

[34]

Adenovirus

Graphene quantum dots

Optoelectronic

Anti-adenovirus, Group II (HEV) polyclonal antibody

Electrostatic bond

8.75 PFU/mL

[51]

Avian influenza virus H7

Gold nanoparticle–graphene nano composites (AuNPs–G)

Electrochemical immunosensor

H7-polyclonal antibodies and H7-monoclonal antibodies

EDC/NHS chemistry

1.6 pg/mL

[41]

Influenza A virus

Graphene oxide-MB–chitosan

Electrochemical

Monoclonal antibodies (H5N1 or H1N1)

Covalent and crosslinked via chitosan

9.4 pM and 8.3 pM

[48]

Cholera toxin

Graphene–polypyrrole

Surface plasmon resonance

Anti-CT

π–π interactions

4 pg/mL

[52]

Rotavirus

Graphene oxide

Photoluminescence

Rotavirus antibodies

Carbodiimide-assisted amidation reaction

105 PFUmL

[35]

Hepatitis C virus

Graphene quantum dots with silver nanoparticles

Electrochemical immunosensing

Anti-HCV antibody

NH2 group of antibody was covalent attachment to the AgNPs

3 fg/mL

[40]

HIV

Peptide- functionalized UCNPs to graphene oxide

Fluorescence

Anti-HIV-1 gp120 antibody

π–π interactions

2 nM

[47]

Celiac disease

Polyamidoamine dendrimer with GQDs on AuNP embedded in MWCNT

Electrochemical

Anti-tTG antibody

EDC/NHS chemistry

0.1 fg per 6 µL

[46]

Alzheimer disease

Magnetic core-plasmonic shell nanoparticle attached hybrid graphene oxide

Surface-enhanced Raman spectroscopy

Cy3 antibody

Amine functionalization

100 fg/mL

[44]

Cardiovascular diseases

Graphene oxide

Electrochemical

PAC1 antibody

EDC/NHS chemistry

–

[36]

Hormones

Reduced graphene oxide

Electrochemical

Anti-GHRL and anti-PYY

EDC–NHS chemistry

1.0 pg/mL GHRL and 0.02 pg/mL PYY

[53]

Cancer

Magnetic Fe3O4@GO composites

Electrochemical

RAB0331 for PSA and Lifeome Biolabs/Cusabio EL008782HU-96 for PSMA

EDC–NHSS

15 fg/mL for PSA and 4.8 fg/mL for PSMA

[45]

Graphene–PYR–NHS

Electrochemical impedance spectroscopy

Monoclonal antibody anti-carcinoembryonic antigen

Non-covalent modification

less than 100 pg/mL

[54]

Reduced graphene and gold nano particle

Electrochemical

Anti-estradiol antibody (curve)

EDC–NHS

0.1 fmol 

[42]

Reduced graphene oxide gold nano particle

Electrochemical

p53 antibodies

Electrostatic interactions

0.088 pg/mL

[43]

β-cyclodextrin functionalized graphene nanosheet

Electrochemical

CEA primary antibody (Ab1), and CEA secondary antibody (Ab2)

EDC–NHS

20 fg/mL

[49]